Peter Vekilov

Dr. Peter Vekilov


Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 June 2002 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
OGOleg Galkin
Oleg Galkin
KCKai Chen
Kai Chen
RNRonald L. Nagel
Ronald L. Nagel
RHRhoda Elison Hirsch
Rhoda Elison Hirsch
PVPeter Vekilov
Peter Vekilov
We show that in solutions of human hemoglobin (Hb)—oxy- and deoxy-Hb A or S—of near-physiological pH, ionic strength, and Hb concentration, liquid–liquid phase separation occurs reversibly and reproducibly at temperatures between 35 and 40°C. In solutions of deoxy-HbS, we demonstrate that the dense liquid droplets facilitate the nucleation of HbS polymers, whose formation is the primary pathogenic event for sickle cell anemia. In view of recent results that shifts of the liquid–liquid separation phase boundary can be achieved by nontoxic additives at molar concentrations up to 30 times lower than the protein concentrations, these findings open new avenues for the inhibition of the HbS polymerization.

23 March 2015 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
KOKaty N. Olafson
Katy N. Olafson
MKMegan A. Ketchum
Megan A. Ketchum
JRJeffrey Rimer
Jeffrey Rimer
PVPeter Vekilov
Peter Vekilov
Significance: Approximately 40% of the global population is at risk for malaria infection and 300–660 million clinical episodes of Plasmodium falciparum malaria occur annually. During the malaria parasite lifecycle in human erythrocytes, heme released during hemoglobin catabolism is detoxified by sequestration into crystals. Many of the common antimalarials are believed to suppress the parasite by inhibiting hematin crystallization. We present, to our knowledge, the first evidence of the molecular mechanisms of hematin crystallization and antimalarial drug action as crystal growth inhibitors. These findings enable the identification and optimization of functional moieties that bind to crystal surface sites, thus providing unique guidelines for the discovery of novel antimalarials to combat increased parasite resistance to current drugs.

30 May 2017 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
KOKaty N. Olafson
Katy N. Olafson
TNTam Q. Nguyen
Tam Q. Nguyen
JRJeffrey Rimer
Jeffrey Rimer
PVPeter Vekilov
Peter Vekilov
Significance: Approximately 3.2 billion people are at risk for malaria. The resistance of malaria parasites to current advanced multidrug treatments, recently recorded to spread out of Southeast Asia, has raised concerns of dire public health consequences. We demonstrate that antimalarial drugs suppress heme detoxification in the malaria parasites in a manner that is counter to the prevailing hypothesis in the field. We find that quinoline-class drugs work by specific interactions with β-hematin crystals, which are the by-product of heme detoxification within the digestive vacuole of the parasites. We also identify specific drug adsorption sites on crystal surfaces. These insights may potentially spur development of antimalarial drugs that overcome parasite resistance through a rational approach, far superior to currently used combinatorial methods.

25 September 2007 in British Journal of Haematology
Verified
Journal Article
Closed access
PDF file
PVPeter Vekilov
Peter Vekilov

1 January 2007 in Biophysical Journal
Verified
Journal Article
Closed access
PDF file
WPWeichun Pan
Weichun Pan
OGOleg Galkin
Oleg Galkin
LFLuis Filobelo
Luis Filobelo
RNRonald L. Nagel
Ronald L. Nagel
PVPeter Vekilov
Peter Vekilov

1 August 2007 in Biophysical Journal
Verified
Journal Article
Closed access
PDF file
OGOleg Galkin
Oleg Galkin
WPWeichun Pan
Weichun Pan
LFLuis Filobelo
Luis Filobelo
RHRhoda Elison Hirsch
Rhoda Elison Hirsch
RNRonald L. Nagel
Ronald L. Nagel
PVPeter Vekilov
Peter Vekilov